Wat is de prijs voor Deltex Medical Group plc (DEMG)

Het prijs van Deltex Medical Group plc (DEMG) is $0.00032657

Wat is de marktkapitalisatie voor Deltex Medical Group plc (DEMG)

Marktkapitalisatie voorDeltex Medical Group plc (DEMG) is $9.03K

Deltex Medical Group plc (DEMG) Aandelensplitsingen

Deltex Medical Group plc, established in 2000 and headquartered in Chichester, UK, specializes in the development, marketing, and distribution of oesophageal Doppler haemodynamic monitoring systems. These TrueVue-branded solutions are available across the United Kingdom, United States, Spain, Canada, and other international territories. The company's product line includes Esophageal Doppler Probes, which offer real-time insights into central vascular blood flow and fluid status by measuring blood velocities in the descending aorta. Loops graphically illustrates aortic blood flow velocity and pressure throughout each heartbeat, while High Definition Impedance Cardiography provides non-invasive monitoring of cardiac function and fluid balance for conscious patients. Additionally, PressureWave utilizes a pulse pressure waveform analysis algorithm, designed for use during patient instability or when the primary ODM mode is inaccessible. Deltex Medical also supports professional development with its Esophageal Doppler Simulator, allowing clinicians to refine their skills in probe insertion, focusing, and waveform interpretation in a controlled, non-patient environment. These sophisticated monitoring tools are crucial in various medical applications, including intensive care for COVID-19 patients, sepsis management, major surgical procedures (such as abdominal, laparoscopic, and spinal surgeries), cardiac interventions, trauma care, organ transplantation, and post-operative monitoring for acute kidney injury.

Jaar	Splitsing	Vermenigvuldiging	Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.

Jaar

Splitsing

Vermenigvuldiging

Cumulatieve vermenigvuldiging

Niet genoeg gegevens voor de verstrekte datums.

Bedrijf	Aantal aandelen splitsingen	Cumulatieve vermenigvuldiging	Land
Abbott Laboratories ABT.US	9	x285	US
Stryker Corporation SYK.US	9	x162	US
Medtronic plc MDT.US	7	x127	IE
Boston Scientific Corporation BSX.US	2	x4	US
Edwards Lifesciences Corporation EW.US	3	x12	US

Bedrijf

Aantal aandelen splitsingen

Cumulatieve vermenigvuldiging

Land